For the Inventor, By the Inventor

Enter assignee name

Momotaro-gene Inc.

USPTO Granted Patents = 10

CIPO Patents = 1

EPO Patents = 9

Forward Citations = 22

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Hiromi Kumon (10 out of 15 patents)

Masami Watanabe (7 out of 8 patents)

Yasutomo Nasu (4 out of 7 patents)

4. Masakiyo Sakaguchi (3 out of 9 patents)

5. Yuji Kashiwakura (3 out of 3 patents)

6. Junichiro Futami (2 out of 7 patents)

7. Nam-Ho Huh (2 out of 5 patents)

8. Chae Ok Yun (1 out of 18 patents)

9. Richard Lowenthal (1 out of 7 patents)

10. Rie Kinoshita (1 out of 2 patents)

11. Hideo Ueki (1 out of 1 patent)

12. Yasuyuki Fujii (1 out of 1 patent)

13. Kazuhiko Ochiai (1 out of 1 patent)

14. Namho Huh (1 out of 1 patent)

15. Kensuke Kawasaki (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 11951182 - Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor (2024-04-09),

2. 11484592 - Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor (2022-11-01),

3. 10782296 - Antibody that specifically recognizes and binds to REIC/Dkk-3 protein having active structure and monitoring of cancer treatment using such anti-REIC/Dkk-3 antibody (2020-09-22),

4. 10071126 - Conditionally replicating adenovirus to express REIC gene (2018-09-11),

5. 9644013 - Partial region polypeptide of REIC/Dkk-3 protein (2017-05-09),

6. 9493776 - System for increasing gene expression and vector comprising the system (2016-11-15),

7. 9222107 - REIC-expressing adenovirus vector (2015-12-29),

8. 8946173 - Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer (2015-02-03),

9. 8658612 - Therapeutic agent for malignant mesothelioma and immunostimulant (2014-02-25),

10. 8614093 - Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity (2013-12-24),

Momotaro-gene Inc. is a leading biotechnology company specializing in genetic research and development. With a focus on innovative solutions for disease prevention and personalized medicine, Momotaro-gene Inc. is committed to improving human health and wellbeing through cutting-edge genetic technologies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#15 in Okayama

#4,290 in Japan

#54,308 in the World

Momotaro-gene Inc.

Forward Citations = 22

16 inventors:

Hiromi Kumon (10 out of 15 patents)

Masami Watanabe (7 out of 8 patents)

Yasutomo Nasu (4 out of 7 patents)

4. Masakiyo Sakaguchi (3 out of 9 patents)

5. Yuji Kashiwakura (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…